NCT04746547View on ClinicalTrials.gov

Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
TuberculosisHiv
Interventions
DRUG

Dolutegravir 50 MG

Twice daily dolutegravir with rifampicin containing TB treatment

DRUG

Dolutegravir 10 MG

Twice daily dolutegravir with rifampicin containing TB treatment

Trial Locations (1)

4001

RECRUITING

King Edward VIII Hospital, Durban

All Listed Sponsors
collaborator

Centre for the AIDS Programme of Research in South Africa

NETWORK

lead

University of KwaZulu

OTHER